FIELD: medicine.
SUBSTANCE: proposed is a group of 7 inventions for the treatment of cough. It includes means for combined treatment of cough, comprising theobromine and codeine to codeine administration at a dose of 3 mg/kg/day, a pharmaceutical composition containing said combination agent application means or formulation for the treatment of cough; means or applying the composition to obtain a medicament for the treatment of cough, a method of treating cough, the use of theobromine in combination with Codeine for a preparation for the treatment of cough (variants) and the use of theobromine in combination with codeine for the treatment of cough (variants).
EFFECT: technical result is to increase the effectiveness of the combination of the claimed anti monotherapy with theobromine and codeine alone.
14 cl, 1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| MEDICAL COMBINATION WITH THEOBROMINE AND USING IT IN TREATMENT | 2010 |
|
RU2519086C2 |
| THEOBROMINE-DECONGESTANT COMBINATION AND APPLICATION THEREOF FOR TREATING COUGH | 2010 |
|
RU2564904C2 |
| ANTITUSSIVE | 2009 |
|
RU2427388C2 |
| ORVEPITANT FOR CHRONIC COUGH TREATMENT | 2016 |
|
RU2746601C2 |
| LIQUID COMPOSITIONS OF PHENYLEPHRINE WITH INCREASED STABILITY | 2007 |
|
RU2468787C2 |
| NOVEL TACHYKININ RECEPTOR ANTAGONIST AND USE THEREOF | 2018 |
|
RU2697414C1 |
| ENANTIOMERICALLY PURE OPIOID DIARYLMETHYL PIPERAZINE AND METHODS FOR USES THEREOF | 2002 |
|
RU2309153C2 |
| ALCOHOL-RESISTANT DRUG COMPOSITIONS | 2019 |
|
RU2811409C2 |
| USE OF 1-(2-(1N-IMIDAZOL-4-YL)ETHYL)PIPERIDINE-2,6-DIONE FOR TREATING COUGH CAUSED BY VIRAL INFECTIONS | 2022 |
|
RU2819722C2 |
| FAST-DISSOLVING PHARMACEUTICAL COMPOSITION | 2011 |
|
RU2566270C2 |
